Results
|
1341.
|
|
|
1342.
|
|
|
1343.
|
|
|
1344.
|
Zinc finger protein 185 is a liver metastasis-associated factor in colon cancer patients. [electronic resource] by
- Furukawa, Daisuke
- Chijiwa, Tsuyoshi
- Matsuyama, Masahiro
- Mukai, Masaya
- Matsuo, Ei-Ichi
- Nishimura, Osamu
- Kawai, Kenji
- Suemizu, Hiroshi
- Hiraoka, Nobuyoshi
- Nakagohri, Toshio
- Yasuda, Seiei
- Nakamura, Masato
Publication details: Molecular and clinical oncology Sep 2014
In:
Molecular and clinical oncology vol. 2
Availability: No items available.
|
|
1345.
|
|
|
1346.
|
Magnetic resonance imaging shrinkage patterns following neoadjuvant chemotherapy for breast carcinomas with an emphasis on the radiopathological correlations. [electronic resource] by
- Tomida, Kaori
- Ishida, Mitsuaki
- Umeda, Tomoko
- Sakai, Sachiko
- Kawai, Yuki
- Mori, Tsuyoshi
- Kubota, Yoshihiro
- Mekata, Eiji
- Naka, Shigeyuki
- Abe, Hajime
- Okabe, Hidetoshi
- Tani, Tohru
Publication details: Molecular and clinical oncology Sep 2014
In:
Molecular and clinical oncology vol. 2
Availability: No items available.
|
|
1347.
|
None [electronic resource] by
- Ochi, Hironori
- Hirooka, Masashi
- Hiraoka, Atsushi
- Koizumi, Yohei
- Abe, Masanori
- Sogabe, Ichiro
- Ishimaru, Yoshihiro
- Furuya, Keizou
- Miyagawa, Masao
- Kawasaki, Hideki
- Michitaka, Kojiro
- Takada, Yasutsugu
- Mochizuki, Teruhito
- Hiasa, Yoichi
Publication details: Molecular and clinical oncology Sep 2014
In:
Molecular and clinical oncology vol. 2
Availability: No items available.
|
|
1348.
|
|
|
1349.
|
|
|
1350.
|
Plasma Bmi1 mRNA as a potential prognostic biomarker for distant metastasis in colorectal cancer patients. [electronic resource] by
- Pun, Jason Chun-Sang
- Chan, Joyce Yee-Jing
- Chun, Bobby Ka-Ming
- Ng, Ka-Wai
- Tsui, Samuel Yung-Kin
- Wan, Timothy Ming-Hun
- Lo, Oswens
- Poon, Jensen Tung-Chung
- Ng, Lui
- Pang, Roberta
Publication details: Molecular and clinical oncology Sep 2014
In:
Molecular and clinical oncology vol. 2
Availability: No items available.
|
|
1351.
|
XELIRI regimen plus continuous treatment with bevacizumab is well-tolerated and effective in metastatic colorectal cancer patients in a second-line setting involving the sequential administration of XELOX and XELIRI. [electronic resource] by
- Suzuki, Koichi
- Takaharu, Kato
- Muto, Yuta
- Ichida, Kosuke
- Fukui, Taro
- Takayama, Yuji
- Tsujinaka, Shingo
- Sasaki, Junichi
- Horie, Hisanaga
- Kawamura, Yutaka J
- Konishi, Fumio
- Rikiyama, Toshiki
Publication details: Molecular and clinical oncology Sep 2014
In:
Molecular and clinical oncology vol. 2
Availability: No items available.
|
|
1352.
|
|
|
1353.
|
|
|
1354.
|
|
|
1355.
|
|
|
1356.
|
|
|
1357.
|
|
|
1358.
|
|
|
1359.
|
|
|
1360.
|
|